Multiple sclerosis is a serious neurological disease that affects 1 in 1000 young adults in Europe and the USA. The development of an effective therapy for this enigmatic disease is plagued by the failure of many treatments to reproduce in patients the promising effects observed in animal models. This review describes a new preclinical model in a non-human primate that might help to bridge the gap between currently used animal models and the patients.,
Drug Discovery Today
Department of Immunology

't Hart, B., Smith, P., Amor, S., Strijkers, G., & Blezer, E. (2006). MRI-guided immunotherapy development for multiple sclerosis in a primate. Drug Discovery Today (Vol. 11, pp. 58–66). doi:10.1016/S1359-6446(05)03673-1